336 related articles for article (PubMed ID: 29199652)
1. Comparison of conventional fractionation (five fractions per week) and altered fractionation (six fractions per week) in stage I and II squamous cell carcinoma of oropharynx: An institutional study.
Poddar J; Sharma AD; Kunikullaya SU; Neema JP
Indian J Cancer; 2017; 54(1):6-10. PubMed ID: 29199652
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two different radiation fractionation schedules with concurrent chemotherapy in head and neck malignancy.
Alam MS; Perween R; Siddiqui SA
Indian J Cancer; 2016; 53(2):265-269. PubMed ID: 28071624
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.
Fallai C; Bolner A; Signor M; Gava A; Franchin G; Ponticelli P; Taino R; Rossi F; Ardizzoia A; Oggionni M; Crispino S; Olmi P
Tumori; 2006; 92(1):41-54. PubMed ID: 16683383
[TBL] [Abstract][Full Text] [Related]
4. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
Krstevska V; Crvenkova S
Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized trial to compare accelerated (six fractions a week) radiotherapy against concurrent chemoradiotherapy (using conventional fractionation) in locally advanced head and neck cancers.
Gupta M; Mahajan R; Kaushal V; Seem RK; Gupta M; Bhattacharyya T
J Cancer Res Ther; 2015; 11(4):723-9. PubMed ID: 26881508
[TBL] [Abstract][Full Text] [Related]
7. Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.
Beitler JJ; Zhang Q; Fu KK; Trotti A; Spencer SA; Jones CU; Garden AS; Shenouda G; Harris J; Ang KK
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):13-20. PubMed ID: 24613816
[TBL] [Abstract][Full Text] [Related]
8. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
9. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
Poulsen MG; Denham JW; Peters LJ; Lamb DS; Spry NA; Hindley A; Krawitz H; Hamilton C; Keller J; Tripcony L; Walker Q
Radiother Oncol; 2001 Aug; 60(2):113-22. PubMed ID: 11439206
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
11. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.
Olmi P; Crispino S; Fallai C; Torri V; Rossi F; Bolner A; Amichetti M; Signor M; Taino R; Squadrelli M; Colombo A; Ardizzoia A; Ponticelli P; Franchin G; Minatel E; Gobitti C; Atzeni G; Gava A; Flann M; Marsoni S
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):78-92. PubMed ID: 12504039
[TBL] [Abstract][Full Text] [Related]
12. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
[TBL] [Abstract][Full Text] [Related]
13. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
[TBL] [Abstract][Full Text] [Related]
14. Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
Zackrisson B; Kjellén E; Söderström K; Brun E; Nyman J; Friesland S; Reizenstein J; Sjödin H; Ekberg L; Lödén B; Franzén L; Ask A; Wickart-Johansson G; Lewin F; Björk-Eriksson T; Lundin E; Dalianis T; Wennerberg J; Johansson KA; Nilsson P
Radiother Oncol; 2015 Oct; 117(1):99-105. PubMed ID: 26427805
[TBL] [Abstract][Full Text] [Related]
15. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
16. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
MacKenzie R; Balogh J; Choo R; Franssen E
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
[TBL] [Abstract][Full Text] [Related]
17. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?
Denham JW; Peters LJ; Johansen J; Poulsen M; Lamb DS; Hindley A; O'Brien PC; Spry NA; Penniment M; Krawitz H; Williamson S; Bear J; Tripcony L
Radiother Oncol; 1999 Aug; 52(2):157-64. PubMed ID: 10577701
[TBL] [Abstract][Full Text] [Related]
18. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.
Overgaard J; Hansen HS; Specht L; Overgaard M; Grau C; Andersen E; Bentzen J; Bastholt L; Hansen O; Johansen J; Andersen L; Evensen JF
Lancet; 2003 Sep; 362(9388):933-40. PubMed ID: 14511925
[TBL] [Abstract][Full Text] [Related]
19. HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
Moon DH; Avkshtol V; Vo D; Ahn C; Sumer B; Day AT; Tillman B; Myers L; Truelson J; Sher DJ
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):157-164. PubMed ID: 37380084
[TBL] [Abstract][Full Text] [Related]
20. Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.
Dwivedi A; Raza MW; Prasad SN; Singh A
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4077-4083. PubMed ID: 38156840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]